Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial
- Simes, R. John
- O'Connell, Rachel L
- Aylward, Philip E
- Varshavsky, Sergei
- Diaz, Rafael
- Wilcox, Robert G
- Armstrong, Paul W
- Granger, Christopher B
- French, John K
- Van de Werf, Frans
- Marschner, Ian C
- Califf, Rob
- White, Harvey D
Publication date
June 2010
DOI Publisher
Mosby-elsevier ISSN
0002-8703 Journal
issn:0002-8703 Citation count (estimate)
19Abstract
Background Despite advances in therapy, global mortality due to acute myocardial infarction remains high. The international Hirulog and Early Reperfusion or Occlusion (HERO-2) trial of 17,073 patients with ST-segment elevation myocardial infarction provided the opportunity to explore international differences in outcomes.status: publishe
Add to ORKG